dexmedetomidine as premedication in children

Premedication: a double-blind randomized study of dexmedetomidine or ketamine alone versus a combination of dexmedetomidine and ketamine

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-14004475

Enrollment

Unknown

Registered

2014-04-02

Start date

2014-04-14

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ophthalmology

Interventions

1:oral ketamine 6mg/kg

2:intranasal dexmedetomidine

Group 3:Intranasal dexmedetomidine and ketamine

Eligibility

Sex/Gender

All

Age

2 Years to 5 Years

Inclusion criteria

Inclusion criteria: children aged 2–5 years, ASA status I–II, with body mass indices of 15–18 kg/m2

Exclusion criteria

Exclusion criteria: a recent history of a respiratory tract infection, a medical history of congenital, hereditary, or mental diseases, severe dysfunction of the CNS or increased intracranial pressure, or a history of dexmedetomidine allergies

Design outcomes

Primary

Measure	Time frame
emotional status;	—

Countries

China

Contacts

Public ContactLi Wenxian

Department of Anesthesiology, EENT Hospital

liwenxian@eentanesthesia.com+86 13917426838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 25, 2026